Clariane SE (Clariane), formerly Korian SE, is an operator of healthcare facilities and medical establishments. The company performs its operations through nursing homes for dependent elderly and fragile people, post-acute and rehabilitation care facilities, psychiatric clinics, home care for dependent elderly persons. Clariane also offers permanent and temporary care services, service flats, home nursing services, and operates specialized clinics and assisted living facilities for elderly people. The company offers home care services in partnership with care nursing homes and healthcare facilities and home-help organizations. It has operations in Belgium, France, Italy and Germany, Italy, the Netherlands, Spain and the UK. Clariane is headquartered in Paris, France.

Gain a 360-degree view of Clariane SE and make more informed decisions for your business Gain a 360-degree view of Clariane SE and make more informed decisions for your business Contact Us
Headquarters France

Address 21 - 25 Rue Balzac, Paris, Ile-de-France, 75008


Telephone 33 1 55375200

No of Employees 59,311

Industry Pharmaceuticals and Healthcare

Ticker Symbol & Exchange CLARI (EPA)

Revenue (2022) $5.4B 12.6% (2022 vs 2021)

EPS XYZ

Net Income (2022) XYZ -577.1% (2022 vs 2021)

Market Cap* $188.7M

Net Profit Margin (2022) XYZ -522.0% (2022 vs 2021)

* As of and is in US$
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Contact Us

Clariane SE premium industry data and analytics

1

Clinical Trials

Determine Clariane SE go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Clariane SE’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Services
Operation Care Nursing Homes and Specialized Clinics
Home Care Services
Medical Care and Clinics
XYZ
XYZ
XYZ
Understand Clariane SE portfolio and identify potential areas for collaboration Understand Clariane SE portfolio and identify potential areas for collaboration Contact Us

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2023 Corporate Changes/Expansions In June, the company changed its name to Clariane SE.
2022 Corporate Changes/Expansions In December, the company announced the openings of 3 Inicea clinics in France.
2021 Acquisitions/Mergers/Takeovers In July, the company announced the acquisition of 90% stake in Santa Croce.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Contact Us
Image for loader

Competitor Comparison

Key Parameters Clariane SE Fresenius SE & Co KGaA Ramsay Generale de Sante Orpea SA LNA Sante SA
Headquarters France Germany France France France
City Paris Bad Homburg Caen Puteaux Vertou
State/Province Ile-de-France Hessen Ile-de-France Ile-de-France Pays-de-la-Loire
No. of Employees 59,311 193,865 35,875 76,160 7,759
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Contact Us
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Contact Us
Executives
Name Position Board Since Age
Jean-Pierre Duprieu Chairman Executive Board 2020 71
Sophie Boissard Chief Executive Officer; Director Executive Board 2020 53
Philippe Garin Chief Financial Officer Senior Management 2018 -
Nicolas Pecourt Chief Communications Officer Senior Management 2022 -
Didier Armaingaud Chief Ethics and Quality-of-Service Officer; Chief Medical Officer Senior Management 2016 -
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Non Dignissim Eros Proin vel Convallis 2024 XY
Gain insight into Clariane SE key executives to enhance your sales strategy Gain insight into Clariane SE key executives to enhance your sales strategy Contact Us
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward